• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Dec. 15, 2021: RBLX, IBRX, AHPI, HLBZ, TEKK

    12/15/21 8:54:16 AM ET
    $AHPI
    $APT
    $FB
    $HLBZ
    Industrial Specialties
    Health Care
    Industrial Specialties
    Health Care
    Get the next $AHPI alert in real time by email

    Today's 5 Stock Ideas:

    • Roblox (RBLX) - A play on the metaverse. Shares sold off Wednesday morning following November metrics from the company. Roblox said average daily active users were up 35% year over year but average bookings per daily active user were down about 8% year over year. Note: Roblox shares had rallied more than 40% over the last two months.

    • ImmunityBio (IBRX) - A play on COVID-19 vaccine manufacturing in Africa. The company's chairman on Tuesday tweeted "History made today! Launch of Vaccine Manufacturing in Botswana."

    • Allied Healthcare Products (AHPI) - A stock that has been sensitive to developments on facemask mandates related to COVID. Note that while this stock has moved with other facemask plays like Alpha Pro Tech (APT) and NovaBay (NBY), the Benzinga newsdesk has not been able to confirm that Allied has a traditional cloth facemask product. It's respiratory product appears to be more like a portable ventilator.

    • Helbiz (HLBZ) - A play on electric scooters. Shares closed up 10% on Tuesday following news of a collab with Facebook/Meta's (FB) Workplace platform.

    • Tekkorp Digital Acquisition Corp. (TEKK) - A Sky News report Tuesday suggested Caliente Interactive, in which online gambling company Playtech owns a 49% stake, is in talks for a $2.5 billion merger with Tekkorp Digital.

    Get the next $AHPI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHPI
    $APT
    $FB
    $HLBZ

    CompanyDatePrice TargetRatingAnalyst
    Roblox Corporation
    $RBLX
    4/22/2026$140.00 → $125.00Buy
    Goldman
    Roblox Corporation
    $RBLX
    4/6/2026$97.00 → $78.00Overweight
    Wells Fargo
    ImmunityBio Inc.
    $IBRX
    3/12/2026$13.00Buy
    BTIG Research
    Roblox Corporation
    $RBLX
    3/4/2026$65.00Neutral
    DA Davidson
    Roblox Corporation
    $RBLX
    2/9/2026$84.00Neutral → Buy
    Roth Capital
    Roblox Corporation
    $RBLX
    2/6/2026$159.00 → $105.00Buy
    Needham
    Roblox Corporation
    $RBLX
    12/12/2025$100.00Overweight → Neutral
    Analyst
    Roblox Corporation
    $RBLX
    12/10/2025$125.00Buy
    B. Riley Securities
    More analyst ratings

    $AHPI
    $APT
    $FB
    $HLBZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rawlings Amy Marie

    4 - Roblox Corp (0001315098) (Issuer)

    4/20/26 7:38:22 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Kaufman Matthew D

    4 - Roblox Corp (0001315098) (Issuer)

    4/15/26 6:36:51 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Reinstra Mark

    4 - Roblox Corp (0001315098) (Issuer)

    4/15/26 6:27:26 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AHPI
    $APT
    $FB
    $HLBZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman reiterated coverage on Roblox with a new price target

    Goldman reiterated coverage of Roblox with a rating of Buy and set a new price target of $125.00 from $140.00 previously

    4/22/26 8:06:58 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Wells Fargo reiterated coverage on Roblox with a new price target

    Wells Fargo reiterated coverage of Roblox with a rating of Overweight and set a new price target of $78.00 from $97.00 previously

    4/6/26 11:39:03 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    BTIG Research resumed coverage on ImmunityBio with a new price target

    BTIG Research resumed coverage of ImmunityBio with a rating of Buy and set a new price target of $13.00

    3/12/26 8:52:16 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHPI
    $APT
    $FB
    $HLBZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ImmunityBio Announces ANKTIVA® Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partnership

    ANKTIVA approved for patients with certain indications of non-muscle invasive bladder cancer and non-small cell lung cancer Commercial availability achieved within two months of announcing MENA partnership with Biopharma and Cigalah Healthcare First patients to be dosed have been identified and will soon receive initial ANKTIVA treatment ImmunityBio, Inc. ((IBRX), a commercial-stage immunotherapy company, today announced that ANKTIVA® (nogapendekin alfa inbakicept) is now commercially available in Saudi Arabia. Initial patients have been identified for treatment across both approved bladder and lung cancer indications in the Kingdom: In combination with Bacillus Calmette-Guérin

    4/21/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Roblox Introduces New Age-Based Accounts and Expanded Parental Controls for Users Under 16

    Roblox Kids and Roblox Select accounts to provide age-based content access and communication defaults for younger users Roblox Corporation (NYSE:RBLX) today announced two new age-based accounts for younger users on Roblox: Roblox Kids for users ages 5 to 8 and Roblox Select for users ages 9 to 15*. When they roll out in early June, these accounts will more closely align content access, communication settings, and parental controls with a user's age. They're also establishing an ongoing selection process for games available to users under 16. This is a continuation of the work Roblox began earlier this year, becoming the first online gaming platform to require facial age checks to access

    4/13/26 8:15:00 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Roblox Announces Roblox Plus, a New Subscription Plan Offering Exclusive Platform Benefits

    Launching April 30, Roblox Plus Provides Value for Players and Recurring Revenue for Creators Roblox (NYSE:RBLX) today announced Roblox Plus, a new subscription plan designed to deliver more value to its users. Available globally starting April 30, 2026, for $4.99 USD per month, Roblox Plus offers discounts on purchases of in-game and avatar items as well as exclusive platform benefits. Roblox will cover these discounts, so that creators continue to make the same amount per item and can earn even more, as subscribers have the ability to spread the same number of Robux across more purchases. Roblox Plus will also benefit creators directly through expanded monetization opportunities. This

    4/10/26 11:45:00 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AHPI
    $APT
    $FB
    $HLBZ
    SEC Filings

    View All

    SEC Form DEFA14A filed by Roblox Corporation

    DEFA14A - Roblox Corp (0001315098) (Filer)

    4/16/26 4:07:15 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEF 14A filed by Roblox Corporation

    DEF 14A - Roblox Corp (0001315098) (Filer)

    4/16/26 4:05:38 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    ImmunityBio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ImmunityBio, Inc. (0001326110) (Filer)

    4/9/26 7:39:06 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHPI
    $APT
    $FB
    $HLBZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mastantuono Gina bought $950 worth of shares (22 units at $43.20) and sold $790 worth of shares (22 units at $35.90) (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/13/26 5:07:32 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Large owner Poplar Point Capital Partners Lp bought $15,967 worth of shares (28,731 units at $0.56) (SEC Form 4)

    4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)

    4/15/25 12:50:08 PM ET
    $NBY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Poplar Point Capital Partners Lp bought $74,519 worth of shares (123,365 units at $0.60) (SEC Form 4)

    4 - NovaBay Pharmaceuticals, Inc. (0001389545) (Issuer)

    4/15/25 12:46:27 PM ET
    $NBY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHPI
    $APT
    $FB
    $HLBZ
    Leadership Updates

    Live Leadership Updates

    View All

    Roblox Expands Board of Directors with the Addition of Dennis Durkin

    Roblox Corporation (NYSE:RBLX), a global immersive gaming and creation platform, today announced the expansion of its Board of Directors with the appointment of Dennis Durkin. Durkin will join as an independent director and serve on the Audit and Compliance Committee and the Leadership Development and Compensation Committee. Durkin has nearly thirty years of experience in the technology and video game sectors, most recently serving as Chief Financial Officer and President of Emerging Businesses at Activision Blizzard. "Our goal is to enable high-fidelity experiences that run seamlessly on any device, anywhere in the world," said David Baszucki, founder and CEO of Roblox. "Dennis has spent

    3/20/26 9:00:00 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era

    VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global immuno-oncology market is set to explode from its current $35 billion level to a massive $185.69 billion by 2035 as the industry moves toward the coordinated activation of the immune system[1]. This surge is being accelerated by the $69.16 billion genomics revolution, which is now integrating advanced profiling into every oncology workflow to pick winning treatments[2]. This strategic push for registration-ready precision assets fuels the 2026 investment case for Oncolytics Biotech Inc. (NASDAQ:ONCY), ImmunityBio (NASDAQ:IBRX), OS Therapies (NYSE-A: OSTX), BioNTech SE (NASDAQ:BNTX),

    1/14/26 10:39:59 AM ET
    $BNTX
    $CMPX
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

    EMERYVILLE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) (the "Company") previously announced a one-time special cash dividend of $0.80 per share for the Company's common stock. The special cash dividend will be payable on September 29, 2025 to stockholders of record as of the close of business on September 15, 2025. Because the payment of the special dividend represents more than 25% of the price of the Company's common stock, NYSE American advised the Company that its common stock will trade with "due bills" representing an assignment of the right to receive the special dividend from the record date of September 15, 2025 through the close of tradi

    9/18/25 4:30:00 PM ET
    $NBY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHPI
    $APT
    $FB
    $HLBZ
    Financials

    Live finance-specific insights

    View All

    Roblox to Report First Quarter 2026 Financial Results on April 30, 2026

    Roblox Corporation (NYSE:RBLX) today announced that it will report the company's first quarter 2026 financial results after the stock market closes on Thursday, April 30, 2026. Roblox will host a conference call to discuss the results at 1:30 p.m. PDT / 4:30 p.m. EDT the same day. The live webcast of the conference call can be accessed from the Roblox investor relations website at ir.roblox.com. Following the call, an audio replay and transcript will be available at ir.roblox.com. About Roblox Roblox is an immersive gaming and creation platform that offers people millions of ways to be together, inviting its community to explore, create and share endless unique games. Our vision is to

    4/9/26 9:00:00 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026

    ImmunityBio, Inc. ((IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across the company's clinical trial pipeline, and to review financial results for the year ended December 31, 2025. Conference Call Details The conference call will begin at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3, 2026. Interested parties may access the conference call through our Investor Relations website, ir.immunitybio.com, under Company — Events & Presentations. Alternatively, individuals can access the call by dialing 1-844-539-3703 or 1-412-652-1273 (internationally).

    2/27/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Roblox to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

    Roblox Corporation (NYSE:RBLX) today announced that it will report the company's fourth quarter and full year 2025 financial results after the stock market closes on Thursday, February 5, 2026. The company will host a conference call to discuss the results at 1:30 p.m. PST / 4:30 p.m. EST the same day. The live webcast of the conference call can be accessed from the Roblox investor relations website at ir.roblox.com. An online replay and transcript of the call will be available on the investor relations website shortly following the call and will remain available for at least 12 months. About Roblox Roblox is an immersive gaming and creation platform that offers people millions of way

    1/12/26 4:00:00 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AHPI
    $APT
    $FB
    $HLBZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Roblox Corporation

    SC 13G/A - Roblox Corp (0001315098) (Subject)

    11/14/24 5:47:35 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Roblox Corporation

    SC 13G/A - Roblox Corp (0001315098) (Subject)

    11/13/24 4:15:38 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by NovaBay Pharmaceuticals Inc.

    SC 13G/A - NovaBay Pharmaceuticals, Inc. (0001389545) (Subject)

    11/8/24 5:31:40 PM ET
    $NBY
    Biotechnology: Pharmaceutical Preparations
    Health Care